| Title： | Expert Consensus on Early Diagnosis and Treatment of Bladder Cancer (2024 edition) |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | Including, but not limited to, medical workers engaged in the clinical diagnosis and treatment of bladder cancer. |
| Evidence classification method： | Based on the Grade scoring criteria |
| Development unit： | Urologic Chinese Oncology Group |
| Registration time: | 2024-03-25 |
| Registration number： | PREPARE-2024CN458 |
| Purpose of the guideline: | Bladder cancer is one of the most common cancers of urinary system, which seriously threatens the life and health of Chinese population. In recent years, with the extension of life expectancy and the acceleration of aging, the incidence and mortality rates of bladder cancer are increasing year by year. Enhancing the detection rate of early bladder cancer and then followed by prompt and effective treatment can not only improve the prognosis and quality of life of patients, but also reduce their economic burden. However, there is still a lack of standardization for early diagnosis and treatment of bladder cancer in China. In order to promote the standardization of early diagnosis and treatment of bladder cancer in China, and to provide relevant clinical workers with corresponding guidance and normative basis, it is necessary to develop expert consensus on early diagnosis and treatment of bladder cancer. |
